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ABSTRACT 
Apoptotic cell clearance (efferocytosis) elicits an anti-inflammatory response by phagocytes, but 
the mechanisms underlying this response are still being defined. While deciphering gene programs 
induced in phagocytes after corpse-ingestion, we uncovered a chloride-sensing signaling pathway 
that controls both the phagocyte appetite and its anti-inflammatory response. First, within 
engulfing phagocytes, the solute carrier 12 (SLC12) family members SLC12A2 and SLC12A4 are 
actively modulated. Interfering with SLC12A2 expression or function led to significantly 
enhanced corpse uptake per phagocyte, while loss of SLC12A4 inhibited corpse uptake. In 
SLC12A2-deficient phagocytes the canonical anti-inflammatory program was replaced by pro-
inflammatory and oxidative stress-associated gene programs. The kinases WNK1-OSR1-SPAK 
that function upstream of SLC12A2 also similarly affected efferocytosis via chloride entry/exit 
across the plasma membrane of phagocytes. The ‘switch’ to pro-inflammatory sensing of apoptotic 
cells was due to disruption of the chloride-sensing pathway and not corpse overload or poor 
degradation, and this pro-inflammatory switch was reversed by a chloride ionophore. Collectively, 
the WNK1-OSR1-SPAK-SLC12A2/SLC12A4 chloride-sensing pathway and chloride flux in 
phagocytes act as key modifiers of how a phagocyte interprets the engulfed apoptotic corpse. 
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Every day, we turnover >200 billion cells in the body via apoptosis as part of normal 
homeostasis1-4. These apoptotic cells are removed by the process of ‘efferocytosis’, which involves 
specific recognition and uptake by professional phagocytes (such as macrophages and dendritic 
cells) and non-professional phagocytes (such as epithelial cells)5-9. Research from a number of 
laboratories has identified a series of steps in efferocytosis, including: the release of soluble factors 
from apoptotic cells (‘find-me’ signals or the ‘smell’ phase) that help the phagocyte sense the 
corpses, the specific ligands on the apoptotic cell surface (‘eat-me’ signals) that are recognized by 
specific receptors on the phagocytes (the ‘taste’ phase), and corpse internalization involving 
extensive cytoskeletal reorganization and subsequent digestion of corpse contents (the ‘ingestion’ 
phase)10-15.  
It is now well-established that defects or failures in proper removal of apoptotic cells can 
result in inflammation with a predilection toward autoimmune disease, including systemic lupus 
erythematosus and chronic inflammation-associated diseases, such as atherosclerosis and 
ulcerative colitis1, 3, 16, 17. Thus, understanding the key molecules and mechanisms that regulate the 
distinct steps of efferocytosis can help target these players and pathways, and potentially modulate 
efferocytosis and inflammation. Ingesting a corpse with potentially ‘dangerous’ contents and 
managing this cargo while maintaining homeostasis is a unique challenge for the phagocyte. An 
added complexity is that most tissues have fewer phagocytes than the number of cells undergoing 
apoptosis, requiring individual phagocytes to successively ingest multiple apoptotic targets1, 2, 4. 
While significant progress has been made in deciphering key membrane receptors on phagocytes 
and ligands on apoptotic cells, our knowledge of molecular players regulating the phagocyte 
response after a corpse is ingested is just emerging. Efferocytic phagocytes also perform two 
concurrent actions: dampen pro-inflammatory mediators and activate production of anti-
inflammatory mediators (i.e. ‘immunosuppressive’)1. Thus, defining molecular players that 
regulate phagocyte responses after corpse uptake and from becoming pro-inflammatory are 
important, and a focus of this work.  
While some genes in phagocytes are induced by specific find-me signals18, others can be 
initiated only by phagocyte:apoptotic cell contact (without corpse internalization)19-22. However, 
our knowledge of specific transcriptional programs initiated after a corpse is internalized is limited. 
To address this, we performed RNAseq analysis, comparing RNA from phagocytes either eating 
apoptotic cells normally, or phagocytes capable of binding but not internalizing corpses (Fig. 1a). 
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Also, to better distinguish the phagocyte-derived RNA (from that of the corpse), we used hamster 
LR73 fibroblasts as phagocytes and apoptotic human Jurkat T cells as targets. We utilized LR73 
fibroblasts to overcome the issue of corpse-derived RNA contamination in the phagocyte RNAseq 
datasets 23;  comparison of hamster versus human coding genomes allowed us to specifically focus 
on phagocyte-specific gene modulation (which was not feasible with mouse versus human 
comparison). In subsequent analyses, we addressed gene programs induced after corpse 
internalization from those induced by corpse contact/soluble factors (Fig. 1a). About 5x more 
genes were modulated in phagocytes by corpse internalization compared to apoptotic cell 
supernatant/contact (Fig. 1a). Among the corpse internalization-specific genes, phagocytes 
upregulated gene programs linked to chloride transport/cell volume, carbohydrate metabolism, 
anti-apoptotic responses, cell adhesion/motility, actin/cytoskeleton rearrangement, and anti-
inflammatory responses (Fig. 1b), while downregulating genes associated with fatty acid oxidation, 
oxidative phosphorylation, pro-apoptotic responses, cholesterol metabolism, oxidative stress, and 
pro-inflammatory responses (Fig. 1b). Thus, upon engulfing an apoptotic corpse, phagocytes 
induce distinct gene programs.  
For further in-depth analysis, we picked SLC12 (solute carrier family 12) pathway genes 
that were part of the cell volume/cell shape gene program for several reasons. First, modulation of 
a number of SLC family members during efferocytosis was recently noted15, although the function 
of SLC12 family is not defined. Second, within the SLC12 family, multiple genes were 
coordinately regulated (Supplementary Table 1), including the transporter Slc12a2 (encoding 
SLC12A2, also called NKCC1), Slc12a4 (encoding SLC12A4, also called KCC1), and the 
upstream kinases that regulate SLC12A2 and SLC12A4, namely Oxsr1 (encoding OSR1) and 
Stk39 (encoding SPAK). Third, SLC12A2 and SLC12A4 are linked to chloride flux into and out 
of cells, in particular in the kidney24, and little is known about the potential role of chloride flux 
during efferocytosis. After confirming the transcriptional changes noted in the RNAseq within the 
SLC12 pathway genes in phagocytes by qPCR (Extended Data Fig. 1a), we addressed the 
functional relevance of this pathway and made several striking observations.  
Surprisingly, targeted deletion of Slc12a2 via CRISPR/Cas9 or siRNA-mediated 
knockdown in LR73 phagocytes resulted in significantly enhanced uptake of apoptotic corpses 
(Fig. 2a and Extended Data Fig. 1b,c). Further, treatment of phagocytes with bumetanide, an 
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inhibitor of SLC12A2 transporter activity, also led to increased corpse uptake (Extended Data 
Fig. 1d,e); bumetanide did not further increase efferocytosis in phagocytes in Slc12a2-deficient  
phagocytes (Extended Data Fig. 1f). This greater uptake was dependent on recognition of PtdSer 
exposed on apoptotic cells (Extended Data Fig. 1g) and was seen in Slc12a2-deficient LR73 
phagocytes over an extended period of co-culture with apoptotic cells (Fig. 2a).  
We next tested SLC12A2 function in professional phagocytes such as macrophages via 
multiple approaches. First, we performed genetic deletion of Slc12a2 ex vivo via CRISPR/Cas9 in 
ER-Hoxb825 immortalized primary bone marrow-derived macrophages, and the loss of SLC12A2 
significantly increased efferocytosis (Fig. 2b and Extended Data Fig. 1h). Second, loss-of-
function mutations in SLC12 family protein members (including SLC12A2) result in an array of 
human diseases24, 26, 27, and incorporating a 11-bp deletion in exon 22 observed in a human patient 
into the mouse Slc12a2 gene locus (Slc12a2mut) results in multiple phenotypes28-30 and early 
lethality in homozygous mice. Using bone marrow from this mouse strain29, we derived 
macrophages (BMDMs) that displayed similarly increased efferocytosis (Fig. 2c). Third, treatment 
of wild type BMDMs (Fig. 2d) or peritoneal macrophages (pMacs; Extended Data Fig. 1e) 
in vitro with the SLC12A2 inhibitor bumetanide also enhanced efferocytosis. Fourth, using two 
different in vivo models, we assessed whether disruption of SLC12A2 function would lead to 
increased efferocytosis. Thymic macrophage engulfment of apoptotic thymocytes induced by 
dexamethasone after bone marrow transplantation (see experimental model; Fig. 2e), and apoptotic 
cell uptake by peritoneal macrophages (Extended Data Fig. 1i) were both enhanced after 
inhibition of SLC12A2. Imaging flow cytometry (ImageStreamX) of Slc12a2-deficient LR73 
phagocytes showed more corpse uptake on a per cell basis (Fig. 2f); whereas control phagocytes 
mostly engulfed 1 to 2 corpses under these assay conditions, ~45% of efferocytic Slc12a2-deficient 
phagocytes contained 4 or more corpses (Fig. 2f). Similarly, fluorescent microscopy of Slc12a2-
deficient macrophages revealed significantly increased efferocytosis on a per-cell basis (Extended 
Data Fig. 1j). Collectively, these data suggest that SLC12A2 acts as a natural brake on apoptotic 
cell uptake, and that interfering with SLC12A2 function leads to increased efferocytosis by both 
professional and non-professional phagocytes. 
The enhanced corpse-derived fluorescence seen with Slc12a2-deficient phagocytes was not 
due to defective corpse degradation based on several criteria. First, we fed apoptotic cells labeled 
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with TAMRA, a dye that directly labels peptides and proteins in apoptotic cells, and monitored 
degradation of TAMRA signal via flow cytometry in both LR73 phagocytes and macrophages 
(Fig. 3a-c). Although rates of degradation varied between LR73 phagocytes and macrophages (i.e. 
non-professional vs. professional phagocytes), when paired control and Slc12a2-deficient 
phagocytes are compared (Fig. 3a-c), the loss of SLC12A2 did not affect the rates of corpse 
degradation. Second, by time lapse microscopy, we observed similar kinetics of corpse degradation 
between control and Slc12a2-deficient phagocytes (Supplementary Videos 1-6). There was no 
significant difference in lysosomal pH in efferocytic phagocytes between control and Slc12a2-
deficient LR73 phagocytes or macrophages (Fig. 3d, e), and inhibition of lysosomal acidification 
did not alter the Slc12a2-deficient LR73 phagocyte or macrophage phenotype of enhanced 
apoptotic cell uptake (Fig. 3f, g). Finally, labeling apoptotic cells with the reagent DQ-Red-BSA, 
whose cleavage by cathepsin protease activity within the acidic phagolysosome induces the DQ-
Red fluorescence, revealed comparable phagolysosomal activity in the control and SLC12A2-
deficient LR73 cells and macrophages; we also noted increased total signal in Slc12a2-deficient 
phagocytes relative to control phagocytes (Fig. 3h, i). Thus, our data suggest that SLC12A2 
dampens phagocyte uptake on a per cell basis, without an apparent effect on lysosomal 
acidification or corpse degradation.  
Interestingly, another SLC12 family member, SLC12A4, acts in opposition to SLC12A2 
during regulatory volume change 31. Although Slc12a4 was only modestly downmodulated 
transcriptionally and by total protein after corpse internalization (Extended Data Fig. 1a and 2a), 
targeting of Slc12a4 by CRISPR/Cas9-mediated deletion or siRNA-mediated silencing in LR73 
phagocytes led to a reduction in apoptotic cell uptake (Extended Data Fig. 2b-e). This reduced 
uptake was not a delay in eating, as this was seen even after 8-hour co-culture with apoptotic cells 
(Extended Data Fig. 2c, e). Thus, SLC12A2 and SLC12A4 may functionally counterbalance each 
other during efferocytosis. Interestingly, when we performed double targeting of Slc12a2 and 
Slc12a4 by siRNA-mediated knockdown of Slc12a4 in the context of Slc12a2-deficient LR73 cells, 
double-deficient phagocytes still showed greater efferocytosis (Extended Data Fig. 2f), 
suggesting that SLC12A2 deficiency is a dominant phenotype over the loss of SLC12A4. 
To address the consequence of Slc12a2 deficiency in efferocytic phagocytes, we performed 
RNAseq analysis of efferocytic control and Slc12a2-deficient phagocytes (Fig. 4a,b). Normally, 
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efferocytosis elicits multiple distinct transcriptional programs in engulfing phagocytes (Fig. 1b). 
Strikingly, Slc12a2-deficient phagocytes showed unexpected changes in several of these 
signatures, including reversals of the anti-inflammatory and oxidative stress signatures, as well as 
a strong increase in a pro-inflammatory gene program (Fig. 4b), suggesting that loss of SLC12A2 
affects how a phagocyte normally interprets apoptotic cell uptake as anti-inflammatory. 
Interestingly, many of the anti-inflammatory and pro-inflammatory genes found to be dysregulated 
in engulfing Slc12a2-deficient phagocytes have genetic /functional linkages with chronic 
inflammatory, auto-inflammatory, and autoimmune diseases (Supplementary Table 2).  
When we re-introduced Slc12a2 cDNA into Slc12a2-deficient efferocytic phagocytes, this 
reversed the greater corpse uptake and pro-inflammatory gene induction, confirming that the 
observed pro-inflammatory signature was in fact due to the absence of SLC12A2 (Extended Data 
Fig. 3a,b). The pro-inflammatory signature noted above could be a general property of phagocytes 
over-eating more corpses. To address this, we used LR73 phagocytes overexpressing the PtdSer 
receptor TIM-4, which increases uptake on a per cell basis 32-35. We then sorted engulfing (i.e. 
CypHer5E+) phagocytes from three conditions: control phagocytes with normal uptake, TIM4 
overexpressing phagocytes with increased uptake, and phagocytes lacking SLC12A2 that also 
have enhanced uptake. Despite eating more corpses, the TIM4-overexpressing phagocytes did not 
show upregulation of pro-inflammatory signature genes, contrasting with Slc12a2-deficient 
phagocytes (Fig. 4c). Further, siRNA-mediated knockdown of Slc12a2 in TIM4 overexpressing 
cells induced upregulation of many of the pro-inflammatory signature genes (Extended Data Fig. 
3c). This latter phenotype was less pronounced than Slc12a2-deficient phagocytes, likely because 
TIM4 is stably overexpressed and siRNA knockdown efficiency can vary between cells in a 
population. Thus, the pro-inflammatory gene signature of Slc12a2-deficient efferocytic 
phagocytes is not simply a corpse-overload effect, and that loss of Slc12a2 alters the anti-
inflammatory response during efferocytosis.  
Both SLC12A2 and SLC12A4 are regulated by upstream kinases, as part of a pathway for 
chloride sensing and chloride flux in cells. When there is chloride efflux from a cell, it is sensed 
by one of the four members of the ‘With-No-lysine Kinase’ (WNK) family of Ser/Thr kinases (Fig. 
5a)24. WNK1, a broadly and ubiquitously expressed member, becomes activated by chloride efflux 
and subsequently phosphorylates the downstream serine/threonine kinases OSR1 and SPAK 
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(encoded by the genes Oxsr1 and Stk39, respectively; Fig. 5a)36-41. In our RNAseq, we noted that 
both Oxsr1 and Stk39 are transcriptionally upregulated in phagocytes after corpse internalization 
(Fig. 1c). OSR1 and SPAK, in turn, phosphorylate both SLC12A4 and SLC12A2 leading to 
decreased SLC12A4-mediated chloride efflux and increased SLC12A2-mediated chloride influx 
(Fig. 5a)31, 39. Although phosphorylation on multi-pass transmembrane proteins are difficult to 
detect, we could observe increased phosphorylation on both SLC12A2 and SLC12A4 proteins in 
a time course of efferocytosis (Extended Data Fig. 4a). Therefore, we next addressed the 
functional relevance of OSR1, SPAK, and WNK1. Knockdown of either OSR1 or SPAK resulted 
in greater apoptotic cell uptake both at early and late time points (Fig. 5b,c and Extended Data 
Fig. 4b,c). Furthermore, deletion/reduction of Wnk1 expression either via CRISPR/Cas9 deletion 
or siRNA-mediated knockdown in LR73 phagocytes resulted in significantly greater corpse uptake, 
essentially phenocopying Slc12a2 deficiency (Fig. 5d,e and Extended Data Fig. 4d-f).  
We then assessed whether WNK proteins regulate rate of apoptotic cell engulfment in vivo. 
After confirming that BMDMs or peritoneal macrophages treated with a pan-WNK inhibitor 
WNK463  42 in vitro enhanced efferocytosis (Fig. 5f,g), we injected WNK463 into the peritoneum 
of mice prior to dexamethasone injection (thymic engulfment model; Fig. 5h) or injection of 
apoptotic Jurkat cells (peritoneal engulfment model; Fig. 5i); in both cases we saw increased 
apoptotic cell uptake by resident macrophages in vivo. Thus, the WNK1–SLC12A2 chloride 
sensing pathway acts as a brake in vitro and in vivo to control the ‘appetite’ of phagocytes for 
apoptotic cells.  
As chloride is important for many biological functions 43-45, we hypothesized that chloride 
flux may also affect different aspects of efferocytosis. As chloride flux is well-linked to cell 
volume regulation, we initially tested the possible impact of chloride on phagocyte cell size during 
efferocytosis. We analyzed the forward scatter area (FSC-A) of engulfing phagocytes by flow 
cytometry, a commonly used indicator of cell size change, which allowed us to gate specifically 
on engulfing phagocytes and assess FSC-A changes in thousands of phagocytes. Interestingly, 
control phagocytes eating corpses routinely had a modest but detectable decrease in cell size, 
suggesting that despite engulfing another cell, the phagocyte volume is actively controlled. While 
Slc12a2-deficient LR73 cells were slightly smaller in size basally, engulfing Slc12a2-deficient 
phagocytes became 40% larger compared to controls (Extended Data Fig. 5a). This was not 
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unique to LR73 phagocytes, as BMDMs from Slc12a2mut mice and Slc12a2-deficient BMDMs 
were also slightly smaller in size basally, but became larger during efferocytosis (Extended Data 
Fig. 5b,c). Similarly, engulfing Wnk1-deficient phagocytes were also larger than control Wnk1-
sufficient phagocytes (Extended Data Fig. 5d). Importantly, the larger size of Slc12a2- or Wnk1-
deficient phagocytes does not appear to be due to ‘over-eating’ per se, as LR73 phagocytes 
overexpressing the PtdSer receptor TIM4 do ingest more corpses, yet do not show larger cell size 
(Extended Data Fig. 5e,f). When we compared Slc12a2 and Slc12a4 deficient phagocytes, 
Slc12a4-deficient cells were modestly larger in size prior to addition of apoptotic corpses, and 
although efferocytosis was attenuated by loss of Slc12a4, these Slc12a4-deficient phagocytes that 
did engulf apoptotic cells were smaller than control phagocytes (Extended Data Fig. 5g). Thus, 
the SLC12 members and upstream regulatory kinases can influence phagocyte cell size during 
efferocytosis. 
We next tested if enhanced engulfment in Slc12a2-deficient phagocytes required chloride 
flux across the plasma membrane. We treated phagocytes with a chloride ionophore tributyltin 
chloride (TBTC), which forces extracellular chloride into the phagocyte cytosol. Treatment with 
TBTC reversed the increased uptake and larger FSC-A/ cell size phenotype after corpse uptake 
observed in Slc12a2-deficient phagocytes (Fig. 6a and Extended Data Fig. 5h). To directly assess 
chloride flux during efferocytosis, we used the cell permeable chloride-sensitive fluorescent dye 
MQAE 46, 47. MQAE reversibly binds chloride in the cytosol, with the fluorescence signal for 
MQAE being quenched (i.e. decreased), at higher cytosolic chloride concentrations, while its 
fluorescence increases at lower chloride concentrations (Fig. 6b)46, 47. Further, MQAE 
fluorescence is not affected by pH or bicarbonate47, allowing its use during phagocytosis assays. 
We first confirmed that phagocytes can be labeled with MQAE and the baseline MQAE 
fluorescence was quenched with forced entry of chloride through TBTC (Extended Data Fig. 6a). 
During efferocytosis, phagocytes maximally engulfing CypHer5E-labeled apoptotic targets 
(CypHer5E ‘bright’) showed less intracellular chloride that is revealed as MQAEhigh fluorescence 
in the flow cytometry readout (Fig. 6b,c and Extended Data Fig. 6b). These data suggest that the 
efflux of cytosolic chloride from the engulfing phagocytes is a component of normal efferocytosis.  
Next, we hypothesized that in engulfing phagocytes, the loss of SLC12A2 would result in 
less cytosolic chloride, while loss of SLC12A4 would result in more cytosolic chloride. siRNA 
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mediated knockdown of Slc12a2 resulted in significantly more engulfing phagocytes with 
significantly lower cytosolic chloride level (Fig. 6d, quantification in Fig. 6e and Extended Data 
Fig. 6c). In contrast, TIM4 overexpressing phagocytes that also take up more corpses had similar 
numbers of efferocytic phagocytes with lower MQAE levels (Extended Data Fig. 6d). A similar 
reduced chloride level (i.e. more MQAEhigh cells) was also seen in Slc12a2mut bone marrow-
derived macrophages actively eating apoptotic cells (Extended Data Fig. 6ef). In contrast, 
targeting Slc12a4 via siRNA resulted in fewer engulfing phagocytes with MQAEhigh phenotype 
(Fig. 6d,e and Extended Data Fig. 6c). We then assessed chloride flux in efferocytic phagocytes 
where the upstream kinases (WNK1/OSR1/SPAK) in the chloride-sensing pathway were knocked 
down. siRNA targeting of Wnk1, Oxsr1, or Stk39 phenocopied the Slc12a2-deficient phenotype, 
displaying many more engulfing phagocytes with a MQAEhigh / low cytosolic chloride profile 
(Extended Data Fig. 6g, quantification in Fig. S6g, and Extended Data Fig. 6i). Disruption of 
any one of the upstream kinases manifested similar results to the loss of SLC12A2-mediated 
chloride influx, further correlating with the observation seen in Extended Data Fig. 4a. These 
data suggest that components of the chloride-sensing pathway including SLC12A2, SLC12A4, 
and the kinases WNK1, OSR1, and SPAK contribute to chloride flux into and out of phagocytes 
during efferocytosis, with chloride influx acting as a ‘brake’ on corpse uptake. 
In addressing a possible mechanism for increased uptake, we found that Slc12a2-deficient 
phagocytes bound more corpses compared to control (Fig. 6f).  Increased binding of corpses by 
Slc12a2-deficient LR73 phagocytes was indicated by both percentage of phagocytes that bound 
corpses and the number of targets bound to phagocytes via MFI. Interestingly, addition of the 
chloride ionophore TBTC, followed by the binding assay, showed reversal of the increased corpse 
binding to Slc12a2-deficient phagocytes (Fig. 6f). While performing these binding experiments, 
we noted that a 6 h TBTC treatment was more effective in seeing significant reversal of binding 
in Slc12a2-deficient phagocytes. This prompted us to go back to the RNAseq data and re-analyze 
expression of genes coding for engulfment receptors in the Slc12a2-deficient phagocytes. In 
Slc12a2-deficient LR73 phagocytes, there was an increase in gene expression for integrin av and 
integrin b5 that have been linked to efferocytosis, as well as molecules linked to integrin dependent 
signaling such as p130Cas (BCAR1), and the small GTPase RhoG and CrkI linked genetically and 
biochemically to efferocytosis via avb5 integrin (Fig. 6g) 48-53. When we tested whether integrin-
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dependent interaction might contribute to the increased efferocytosis observed with Slc12a2-
deficient phagocytes, an RGDS peptide added prior to addition of apoptotic targets partially 
inhibited the increased corpse binding to Slc12a2-deficient phagocytes (almost similar to the 
positive control for blocking with annexin V) (Fig. 6h). Collectively, these data support a 
mechanism that the altered chloride efflux in the Slc12a2-deficient phagocytes leads to enhanced 
apoptotic cell uptake, in part, via increased expression of integrins and greater binding of apoptotic 
targets. While this increased integrin expression is clearly one mechanism, there could also be 
other modalities that remain to be explored.  
To test the in vivo linkage between this chloride-sensing pathway and the interpretation of 
apoptotic cells as anti- vs. pro-inflammatory, we used a well-established apoptotic cell clearance 
model of low-dose LPS-induced acute lung inflammation54. In this model (schematic in Fig. 7), 
low-dose LPS is administered intranasally, eliciting neutrophil and monocyte infiltration, with 
induction of pro-inflammatory cytokines including TNFa, IL-6, and IL-1. After 24 h, neutrophils 
undergo apoptosis and are engulfed by lung macrophages, leading to resolution of the 
inflammatory response54. At 24 h post LPS inoculation, after the initial onset of the LPS-induced 
response, we intraperitoneally administered either the SLC12A2 inhibitor bumetanide or the pan-
WNK kinase inhibitor WNK463. After an additional 12 h, bronchoalveolar fluid (BALF) was 
assessed for the resolution of the inflammatory response. Strikingly, mice treated with the 
SLC12A2 inhibitor bumetanide had significant levels of the pro-inflammatory cytokines IL-1a, 
IL-1b, IL-6, and TNFa, which were absent in vehicle control-treated mice (Fig. 7a). Additionally, 
bumetanide treated mice failed to upregulate the pro-resolution cytokine IL-10 (Fig. 7a). The pan-
WNK inhibitor WNK463 had a similar effect, albeit less pronounced, on inflammation resolution 
(Fig. 7a). We also isolated Siglec F+ alveolar macrophages from the same mice, and detected 
upregulation of the pro-inflammatory gene signature in macrophages treated with either 
bumetanide or WNK463 (Fig. 7b). The increased inflammatory cytokine production in the BALF 
correlated with efferocytic thymic macrophages treated with WNK463 ex vivo producing 
significant amounts of these pro-inflammatory cytokines (Extended Data Fig. 7a).  
RNAseq of efferocytic Slc12a2-deficient phagocytes showed a robust change in gene 
programs associated with oxidative stress (Fig. 4b). Oxidative stress, induced by accumulation of 
reactive oxygen species (ROS), is known to induce pro-inflammatory cytokine production, 
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including IL-1b55. Consistent with our RNAseq data, inhibition of the chloride-sensing pathway 
resulted in increased accumulation of ROS in efferocytic phagocytes in vitro (Fig. 7c and 
Extended Data Fig. 7b). Thymic macrophages treated with WNK463 during dexamethasone-
induced apoptotic thymocyte clearance also showed significantly higher accumulation of ROS 
than vehicle treated controls (Figure 7d). Thus, the chloride-sensing pathway in phagocytes 
involving WNK and SLC12A2 is an important part of ROS regulation and normal suppression of 
the inflammatory response during efferocytosis in vivo.  
Lastly, we asked whether forcing entry of extracellular chloride can reverse the pro-
inflammatory responses. We allowed control or Slc12a2-deficient phagocytes to engulf apoptotic 
cells normally for 1 hour (by which time significant number of phagocytes have already engulfed 
but not digested corpses) and added the chloride ionophore TBTC. Treatment with TBTC 
significantly suppressed many of the pro-inflammatory genes in Slc12a2-deficient phagocytes, 
with the others (Myd88, Nfkb2, and Tlr4) being modestly decreased (Fig. 7e). Thus, forced chloride 
influx was sufficient to suppress the pro-inflammatory gene signature induced by Slc12a2 
deficiency during efferocytosis.     
The data presented in this manuscript have several implications for efferocytosis in general 
and specifically for understanding how phagocytes interpret ingested apoptotic corpses as anti-
inflammatory. First, this work identifies a previously unknown regulatory step that is induced 
within phagocytes after a corpse is internalized that involves SLC12A2 and kinases in the chloride-
sensing pathway. Second, this chloride-sensing pathway controls cytosolic chloride flux during 
efferocytosis. Third, chloride flux during efferocytosis impacts the appetite of a given phagocyte, 
acting as a natural brake in efferocytosis. Fourth, when a phagocyte has disruption in the function 
of SLC12A2 or the upstream kinases, phagocytes fail to properly induce an anti-inflammatory 
gene program, a hallmark of efferocytosis. Further, Slc12a2-deficient phagocytes actively switch 
from a homeostatic efferocytosis signature to a pro-inflammatory program; this is not simply due 
to corpse overload as phagocytes engulfing multiple corpses in response to PtdSer receptor 
overexpression do not show a similar pro-inflammatory signature. A concept that has emerged 
from these studies is that the SLC12A2 pathway and chloride flux represent a ‘reversible switch’ 
controlling the anti- vs. pro-inflammatory response of a phagocyte after apoptotic cell uptake and 
could potentially be targeted for both dampening and promoting an immune response. Interestingly, 
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monogenic human diseases, such as Bartter’s Syndrome or Gitelman’s Syndrome, are caused by 
mutations in the SLC12 family of proteins as well as their regulators. The primary symptoms 
manifested in this constellation of syndromes are typically treatable; however, several case reports 
have suggested inflammatory disease sequelae that arise at later stages56-59. Whether routine 
efferocytosis is differentially ‘interpreted’ due to mutations in SLC12 pathway members is a 
possibility worthy of further exploration. In a recent study, treatment of RAW 264.7 macrophages 
with LPS resulted in increased uptake of fluorescent E. coli bioparticles, as well as increased 
proinflammatory cytokine release and this was attenuated via bumetanide pre-treatment60. This 
earlier work focused on SLC12A2 function in bacterial clearance/LPS responses (not 
efferocytosis); nevertheless, future studies are required to determine how the SLC12 pathway 
functions in different forms of phagocytosis and the associated immune responses, including 
bacterial, antibody-mediated, and complement-mediated clearance.  
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Fig. 1: Identification of corpse internalization-dependent gene programs in efferocytic 
phagocytes.  
 
(a) Schematic for identifying the gene programs induced after corpse internalization. LR73 cells 
(fibroblasts from C. griseus) as phagocytes were cultured with apoptotic human Jurkat T cells 
in the absence (control) or presence of Cytochalasin D, which inhibits the uptake, but still 
allows corpse binding and phagocyte response to soluble signals released by apoptotic cells. 
By comparative analysis of transcriptional changes with and without Cytochalasin D, we 
could distinguish changes in gene expression due to soluble factors derived from apoptotic 
cells and corpse-contact, versus those requiring corpse-internalization. RNAseq of phagocytes 
treated with Cytochalasin D alone were also used to normalize. Analysis of transcripts that 
were differentially regulated during efferocytosis revealed a significant number of genes that 
were corpse internalization-dependent, as well as those that did not require internalization (see 
methods).  
(b) Pathway analysis reveals a distinguishable pattern of gene program changes after corpse 
internalization. Shown are bidirectional plots representing the number of genes associated 
with a specific function / pathway that were significantly differentially regulated in response 
to either ‘soluble factors / corpse contact’ versus ‘corpse internalization’. The transcriptional 
program that falls under general ‘cell volume/size’ regulation (green highlight) was chosen 
for further analysis. See also Supplementary Table 1. 
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Fig. 2: The SLC12A2 transporter functions as a ‘brake’ on apoptotic cell uptake.  
(a) Slc12a2-deficient phagocytes engulf more apoptotic cells. Control or Slc12a2-deficient GFP+ 
LR73 phagocytes were co-cultured with CypHer5E-labeled apoptotic Jurkat cells for 2h and 
8h, and analyzed by flow cytometry. Data are presented as phagocytosis index. Data represent 
n=4 independent experiments, shown as mean ± SEM. T-test, ***p < .001. 
(b) Slc12a2-deficient BMDMs engulf more apoptotic corpses. Immortalized Cas9-GFP ER-
Hoxb8 macrophage progenitors bearing Slc12a2 or scrambled control guide RNAs, then 
differentiated into mature BMDMs, and assessed for uptake with CypHer5E-labeled apoptotic 
Jurkat cells for 1 h. Data represent n=4 independent experiments. Shown as mean ± SEM. T-
test, ***p < .001. 
(c) Macrophages from Slc12a2mut mice bearing a SLC12A2 loss-of-function mutation engulf 
more apoptotic corpses. BMDMs from Slc12a2mut mice or littermate controls were co-cultured 
with CypHer5E-labeled apoptotic thymocytes for 1 h and analyzed for efferocytosis. Data 
represent n=4 independent experiments. Shown as mean ± SEM. T-test, ***p < .001. 
(d) In vitro inhibition of SLC12A2 in BMDMs increases apoptotic corpse uptake. BMDMs pre-
treated for 1 h with 10µM Bumetanide were incubated with CypHer5E+ apoptotic Jurkat cells 
for 1h in the presence of drug or vehicle. Data from n=2 independent experiments. 
(e) In vivo inhibition of SLC12A2 in thymic macrophages increases apoptotic corpse uptake. 
(left) CD45.2 bone marrow was mixed with bone marrow from mice (CD45.1/2) expressing 
TdTomato and injected into CD45.1 congenic recipient mice. After 8 weeks, recipient mice 
were treated with dexamethasone along with vehicle or 10µM Bumetanide. After 6h, CD45.2+ 
thymic macrophages were analyzed for engulfment of TdTomato+ cells. Data represent n=3 
independent experiments, shown as mean ± SEM. T-test, ***p < .001. (f) Slc12a2-deficient	 phagocytes	 engulf	more	 apoptotic	 corpses	 on	 a	 per	 cell	 basis. Two 
hundred individual Slc12a2-deficient LR73 cells that took up apoptotic cells (CypHer5E+) 
were analyzed per replicate using ImageStream flow cytometry. Individual CypHer5E+ 
puncta (white arrow) were tabulated for individual phagocytes and scored as having 1, 2, 3 or 
≥4 CypHer5E+ events. Fraction of the total CypHer5E+ population with different events per 
cell is shown. N=2 independent experiments. scale bar = 20 µM.	 	
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Fig. 3: Increased engulfment in SLC12A2 deficient phagocytes is not due to failure to 
degrade apoptotic cells  
(a) Corpse degradation is not affected by Slc12a2 deficiency in non-professional phagocytes. 
LR73 phagocytes were co-cultured with TAMRA-SE-labeled apoptotic Jurkat cells for 2h, 
washed, and cultured for another 6h to monitor degradation of TAMRA signal. Data are from 
n=2 independent experiments and shown as mean ± SEM. T-test, ns = not significant.  
(b, c) Rate of corpse degradation is not affected in Slc12a2-deficient BMDMs. BMDMs lacking 
Slc12a2 or expressing a mutant Slc12a2 were co-cultured with TAMRA-SE-labeled apoptotic 
Jurkat cells for 1h, washed, then cultured for an additional 12 h to monitor degradation of 
TAMRA signal. Data are from n=3 independent experiments. Data shown as mean ± SEM. 
T-test, ns = not significant. (d,	 e)	Efferocytic Slc12a2-deficient phagocytes do not have disrupted lysosomal acidification. 
LR73 cells or macrophages were labeled with the lysosomal pH indicator LysoSensor prior 
to co-culture with CypHer5E+ apoptotic cells and analyzed for LysoSensor MFI. Data are 
presented as the Geometric Mean Fluorescence Intensity (MFI). Flow cytometry plot (left) or 
summarized data from n=3 experiments (right) are shown as mean ± SEM. T-test, ns = not 
significant. 
(f, g) Slc12a2-deficient phagocytes engulf significantly more corpses without an effect on 
lysosomal acidification. Slc12a2-deficient LR73 phagocytes or macrophages were mixed with 
CellTrace Far Red-labeled apoptotic Jurkat cells (2h or 1h, respectively) and the lysosomal 
acidification-inhibitor Bafilomycin A. Data from n=3 independent experiments are shown as 
mean ± SEM. T-test. **p < .01. 
(h, i) Phagolysosomal function is preserved in Slc12a2-deficient phagocytes. Control or Slc12a2-
deficient LR73 cells or BMDMs were co-cultured with DQ-Red-BSA labeled apoptotic Jurkat 
cells for 2h and the fluorescence from DQ-Red that arises within phagolysosomes assessed. 
Data are from n=3 independent experiments and shown as mean ± SEM. T-test, **p < .01. 
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Fig. 4. Loss of SLC12A2 disturbs the homeostatic efferocytosis-associated gene signature. 
(a) Schematic of the RNAseq analysis of Slc12a2-deficient phagocytes engulfing apoptotic cells. 
Slc12a2-deficient or control LR73 phagocytes were cultured with CypHer5E-labeled apoptotic 
Jurkat cells for 2 h. Phagocytes were collected and CypHer5E+ cells (i.e. engulfing 
phagocytes) were sorted directly into lysis buffer for RNAseq analysis. Image representative 
of 4 experiments. 
(b) Slc12a2-deficient phagocytes display altered homeostatic efferocytosis transcriptional 
signatures. RNAseq data from Slc12a2-deficient and control phagocytes was analyzed for 
expression of the corpse internalization-dependent transcriptional programs including the anti-
inflammatory, pro-inflammatory, and oxidative stress programs identified in Fig. 1. Shown are 
heatmaps representing differentially expressed pro-inflammatory, anti-inflammatory, and 
oxidative stress genes in control vs Slc12a2-deficient efferocytic phagocytes. Data are from 
four independent experiments. See also Extended Data Fig. 3 and Supplementary Table 2. 
(c) Enhanced corpse uptake due to PtdSer receptor overexpression does not induce a pro-
inflammatory gene signature. Control, Slc12a2-deficient, and Tim4 expressing LR73 cells 
were fed with Jurkat cells for 2 h. CypHer5E+ phagocytes were sorted, and the expression of 
selected pro-inflammatory genes was determined by qPCR. Data are from n=3 independent 
experiments. Data shown as mean ± SEM. T-test, ***p < .001. ns = not significant. 
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Fig. 5. SLC12 family-linked kinases also regulate efferocytosis. 
(a) Model of the WNK1-OSR1/SPAK-SLC12A2/SLC12A4 pathway of electroneutral chloride 
sensing and chloride flux. WNK1 is inactive bound to chloride. Upon chloride efflux, WNK1 
is activated and phosphorylates either OSR1 or SPAK (or both). OSR1 and SPAK then 
phosphorylate both SLC12A2 and SLC12A4, with phosphorylation opening SLC12A2 
(allowing chloride influx) and closing SLC12A4 (blocking chloride efflux). 
(b-d) Reduction in Oxsr1 (OSR1), Stk39 (SPAK), and Wnk1 results in a similar increase in 
apoptotic cell clearance as Slc12a2 deficiency. siRNA-mediated reduction of Oxsr1 (OSR1, 
b), Stk39 (SPAK, c), or Wnk1 (d) in LR73 phagocytes display significantly increased apoptotic 
cell uptake. Phagocytosis index is relative to control phagocytes (2h). Data represent at least 
four independent experiments for 2 h and two independent experiments for 8 h time points.  
(e) WNK1 deficiency phenocopies Slc12a2 deficiency in phagocytes during efferocytosis. LR73 
phagocytes lacking WNK1 (via CRISPR/Cas9-mediated deletion) were co-cultured with 
CypHer5E-labeled apoptotic Jurkat cells for 2 h and 8 h. Phagocytosis index relative to control 
shown from n=4 independent experiments. One-Way ANOVA, ***p < .001.  
(f, g) Inhibition of WNK leads to efferocytosis increase by BMDMs and peritoneal macrophages 
in vitro. CFSE-labeled BMDMs or peritoneal macrophages were pre-treated with vehicle or 
WNK463 for 1h prior to and during efferocytosis with CypHer5E+ apoptotic Jurkat cells. 
Phagocytosis index relative to vehicle-treated phagocytes is shown from at least n=3 
independent experiments as (f) mean ± SEM. (g) mean ± SD, T-test, ***p < .001. 
 (h) In vivo inhibition of WNK in thymic macrophages increases apoptotic corpse uptake. (left) 
Similar to Fig. 2e. (right) Thymic macrophages were analyzed for engulfment of TdTomato+ 
cells. Data from three independent experiments (n=5 mice per condition) shown as mean ± 
SEM. T-test, ***p < .001. 
(i) WNK inhibitor enhances efferocytosis by peritoneal macrophages in vivo. Mice were injected 
(i.p) with WNK463 for 30 min prior to co-injection of CypHer5E-labeled apoptotic Jurkat cells 
(with WNK463 inhibitor). After 30 min, CD11b+ F4/80+ macrophages were analyzed for 
apoptotic cell uptake. Data are from three independent experiments (Vehicle n=5, WNK463 
n=6), shown as mean ± SEM. T-test, **p < .01. 
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Fig. 6. Chloride flux during efferocytosis. 
(a) Elevated intracellular chloride level impairs efferocytosis and suppresses increased engulfment 
in Slc12a2-deficient phagocytes. Control or Slc12a2-deficient LR73 phagocytes were co-
cultured with CypHer5E-labeled apoptotic Jurkat cells for 2h with or without TBTC, and 
efferocytosis assessed. Data represent n=2 independent experiments.  
(b, c) MQAE-mediated monitoring of intracellular chloride during efferocytosis. LR73 phagocytes 
were labeled with MQAE (b), and co-cultured with or without CypHer5E+ apoptotic 
thymocytes for 2h (shown) or 6h (Extended Data Fig. 6b). Gated efferocytic phagocytes 
(CypHer5E high) show proportionally lower chloride levels, i.e. MQAE "bright" (c). Plots 
represent three independent experiments.  
(d, e) Disruption of Slc12a2 or Slc12a4 affects chloride flux during efferocytosis. Slc12a2 and 
Slc12a4 were targeted via siRNA, and MQAE-labeled LR73 cells were co-cultured with 
CypHer5E-labeled apoptotic thymocytes for 2h. Representative plots (d), and compiled data 
from independent experiments (e) of CypHer5E+ MQAE “bright” (see also Extended Data 
Fig. 6c) phagocytes are shown. Data from n=3 independent experiments (bar = mean). One-
way ANOVA, ***p < .001. 
(f) Increased corpse binding in Slc12a2-deficient phagocytes can be rescued using the chloride 
ionophore TBTC. Slc12a2-deficient or control GFP+ LR73 phagocytes were pre-treated with 
or without TBTC (6h) and Cytochalasin D (1h), then co-cultured with TAMRA-SE-labeled 
apoptotic cells and assessed for binding via flow cytometry. Frequency of bound corpses (left) 
and corpse-derived fluorescence (MFI, right panel) were assessed. Data represent n=3 
independent experiments (bar = mean ± SD). Two-way ANOVA, ** p < .01, *** p < .001. 
(g) Slc12a2-deficient phagocytes exhibit a robust integrin pathway associated signature. Heatmap 
of genes coding for integrin and downstream signaling molecules (red) in efferocytic Slc12a2-
deficient phagocytes compared to control phagocytes (from RNAseq data of Fig. 4a). 
(h) Slc12a2-deficient phagocytes exhibit increased phosphatidylserine- and integrin-dependent 
binding of apoptotic cells. Similar to (f), except ACs were pre-treated with Annexin V or 
phagocytes pre-treated with RGDS peptide for 30 min. Data represent n=3 independent 
experiments (bar = mean ± SD). Two-way ANOVA, * p < .05, ** p < .01, *** p < .001.  
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Fig. 7. The SLC12 pathway and chloride flux are required to prevent inflammatory apoptotic 
cell clearance. 
(a, b) In vivo inhibition of SLC12A2 or WNK family members impairs inflammation resolution. 
(a) Schematic of in vivo LPS-inflammation model in the lung (top) and analysis of pro-
inflammatory and anti-inflammatory cytokines in bronchoalveolar lavage fluid (cell-free) 
assessed via Luminex assay (bottom). (b) Isolated alveolar macrophages were assessed for 
pro-inflammatory genes via qPCR. n.d. = not detected, Data from vehicle (n=10 except n=5 
for IL-10), bumetanide (n=5 except n=9 for IL-1b), and WNK463 (n=9, except n=5 for IL-
10) biological replicates, shown as mean ± SEM. One-way ANOVA, *p < .05, **p < .01, 
***p < .001. 
(c) The SLC12 pathway affects ROS levels in non-professional phagocytes in vitro. LR73 
phagocytes were labeled with oxidative stress indicator CellROX, which fluoresces in 
response to oxidation by ROS. Phagocytes were co-cultured with apoptotic cells, and levels 
of ROS assessed by flow cytometry. Data from n=4 independent experiments are shown as 
mean ± SEM. T-test, ***p < .001. 
(d) The SLC12 pathway regulates ROS levels by professional phagocytes in vivo. C57BL/6J mice 
were treated with dexamethasone (Dex) to induce thymocyte death and co-injected with either 
WNK463 or vehicle. Thymic macrophages were isolated after 6 hours, and analyzed for 
oxidative stress using CellROX readout via flow cytometry. Data are from two independent 
experiments (n=7 mice), and shown as mean ± SEM. T-test, ***p < .001. 
(e) Forced chloride influx suppresses pro-inflammatory gene signature. Control or Slc12a2-
deficient phagocytes were co-cultured with apoptotic cells for a total of 2 h. At the 1h time 
point with apoptotic cells, the chloride ionophore TBTC was added to half of the wells in each 
condition. Phagocytes were harvested and assessed via qPCR for the presence of pro-
inflammatory genes shown. Data are from n=2 independent experiments.  
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Supplementary Figure S1. Related to Figure 1 & 2.
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Supplementary Figure S2. Related to Figure 1 & 3
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